Early add-on therapy with PCSK9 inhibitor appears safe in patients post heart attack
Compared with a placebo, the addition of the injectable cholesterol-lowering drug alirocumab to high-intensity statin treatment in patients who have had a heart attack resulted in twofold greater reductions in three key measures ...
Apr 4, 2022
0
13